As of Jun 22
| -0.44 / -6.56%|
The 4 analysts offering 12-month price forecasts for Avadel Pharmaceuticals PLC have a median target of 15.00, with a high estimate of 24.00 and a low estimate of 13.00. The median estimate represents a +139.23% increase from the last price of 6.27.
The current consensus among 4 polled investment analysts is to Buy stock in Avadel Pharmaceuticals PLC. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.